Head-to-head · WeighScore
TelePeptide vs Trava Health
The verdict
Trava Health takes it — 68.6/100 to 62.3/100.
Trava Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | TelePeptide | Trava Health |
|---|---|---|
| WeighScore | 62.3/100 | 68.6/100 |
| Grade | C | C |
| Scorecard rank | #273 | #144 |
| Semaglutide | $199/mo (starting dose, annual plan, compounded oral) | $119/mo (starting dose, compounded) |
| Tirzepatide | $219/mo (starting dose, annual plan, compounded oral) | $198/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #273 · C
Strengths
- LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
- All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
- Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
- 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
- 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime
Where it loses points
- Compounded medications are not FDA-approved; no pharmacy partner named publicly
- Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
- Labs not included in any plan
- Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
- Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average
Graded #144 · C
Strengths
- Six named compounding pharmacy partners disclosed in 3rd-party reviews
- Independent batch testing by Eagle Analytical (FDA-registered lab)
- Free overnight shipping included
- No membership fee — pay only for medication
- HSA/FSA eligible
Where it loses points
- No LegitScript accreditation badge surfaced
- BBB F rating with 2 unanswered complaints (BBB file opened 2025-07-07)
- Clinician roster page returns 404 — no public team listing
- Founder/CEO not publicly named on site
- Higher dose pricing gated behind questionnaire (not transparent on public page)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.